Cell Growth & Differentiation, Vol 7, Issue 12 1713-1721, Copyright © 1996 by American Association of Cancer Research

ARTICLES

Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells

AR Buckley, MA Leff, DJ Buckley, NS Magnuson, G de Jong and PW Gout
Department of Pharmacology and Toxicology, University of North Dakota School of Medicine, Grand Forks 58202-9037, USA.

Whereas Nb2-11 lymphoma cells critically require prolactin (PRL) for growth, Nb2-SFJCD1 subline cells are growth factor independent. Treatment with the differentiating agent, sodium butyrate (NaBT), has been demonstrated previously to lead to growth arrest of Nb2-SFJCD1 cells and a transient reversion to PRL growth requirement following removal of NaBT. In the present study, the relation of NaBT-induced growth arrest to the cell cycle was examined using flow cytometry, and the effect of PRL on expression of the immediate-early proto-oncogenes, pim-1 and c-myc, in NaBT-pretreated cultures was evaluated. Treatment of Nb2-SFJCD1 cells with 2 mM NaBT for 72 h caused growth arrest in the majority of the cells in the G1 phase of the cell cycle, an effect similar to that produced by lactogen deprivation in PRL-dependent Nb2 cultures. The addition of PRL stimulated a concentration-dependent re-entry into the cell cycle. In other experiments, NaBT treatment significantly reduced the steady-state levels of pim-1 and c-myc mRNA. Stimulation with PRL induced a rapid and concentration-dependent biphasic accumulation of each mRNA with similar kinetics. Maximal expression of both proto-oncogenes occurred within 2-4 h and after 12 h. Results from mRNA stability studies suggest that the observed increases in expression of pim-1 and c-myc most likely do not reflect increased stability of the transcripts. The results indicate that NaBT-induced differentiation in autonomous Nb2-SFJCD1 causes growth arrest of the cells in the G1 phase of the cell cycle and reduces the basal levels of pim-1 and c-myc mRNAs. Mitogenic stimulation with PRL reinitiates cell cycle progression characterized by biphasic expression of each proto-oncogene. It is suggested that NaBT is a useful tool for investigation of the malignant progression from growth factor dependency to autonomy in the Nb2 lymphoma paradigm.

This article has been cited by other articles:

				C. M. Karp, H. Pan, M. Zhang, D. J. Buckley, L. A. Schuler, and A. R. Buckley Identification of HRPAP20: A Novel Phosphoprotein that Enhances Growth and Survival in Hormone-Responsive Tumor Cells Cancer Res., February 1, 2004; 64(3): 1016 - 1025. [Abstract] [Full Text] [PDF]

				A R Buckley Prolactin, a lymphocyte growth and survival factor Lupus, October 1, 2001; 10(10): 684 - 690. [Abstract] [PDF]

				K. E. Borg, M. Zhang, D. Hegge, R. L. Stephen, D. J. Buckley, N. S. Magnuson, and A. R. Buckley Prolactin Regulation of pim-1 Expression: Positive and Negative Promoter Elements Endocrinology, December 1, 1999; 140(12): 5659 - 5668. [Abstract] [Full Text]

				D. BERNHARD, M. J. AUSSERLECHNER, M. TONKO, M. LÖFFLER, B. L. HARTMANN, A. CSORDAS, and R. KOFLER Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts FASEB J, November 1, 1999; 13(14): 1991 - 2001. [Abstract] [Full Text]